Merck & Co’s Kymera Therapeutics KYMR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$33.7M	Hold	772,165	–	–	15.63%	3
2025 Q1	$21.1M	Hold	772,165	–	–	12.86%	3
2024 Q4	$31.1M	Buy	+772,165	New	+$31.1M	12.04%	3